Diabetes  /  Economic Value

Despite recent advances, diabetes continues to be a major health threat for at least 29 million Americans who have it and the 86 million Americans with prediabetes. The biggest concerns for individuals with the disease are its many complications and co-morbidities; which can cause vision loss, heart disease, stroke, and other debilitating medical conditions. With the aging of the population and the rise in risk factors like obesity, these problems are going to skyrocket, making medical innovation more critical than ever.

18 Matching Facts

Search matching Facts:
No results to display
    • DR Treatment Savings in the US
      Every year, the U.S. saves an estimated $1.6 billion by treating DR.  
    • Economics of DR Treatment
      Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
    • The use of insulin pumps create net cost savings, including $5886 annually per person affected and $34.9 million in increased tax revenue  
    • The initiation of insulin therapy in the management of type 2 diabetes involves an approximate 10% increase in total health care expenditures initially, although this is offset by the consistent…  
    • In a community-based pharmaceutical care services program for 194 participants in 2001, days of sick time decreased at each interval (each year for 1-5 years) for one employer, with estimated…  
    • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring and collaborative drug therapy management…  
    • In a study investigating the effectiveness of diabetes management services from clinical pharmacists on patients, based on an estimated savings of $820 for each 1% decrease in A1c, the reduction…  
    • Evaluation of a Cooperative Extension Service diabetes education program showed improved nutrition knowledge, anthropometric measures and glucose control. These improvements reduced medical costs by approximately $94,010 for the 62 participants.  
    • In a community pharmacy health management program called the Diabetes Ten City Challenge, in which 573 patients with diabetes participated, the average total healthcare costs per patient per year were…  
    • A statin initiation intervention aimed at Medicare Part D prescription drug plan subscribers with diabetes or coronary artery disease was successful in increasing statin use among this group of members…  
    • Average direct medical costs over time, in 2001, for 194 participants in a community-based pharmaceutical care services program for patients with diabetes.  
    • The cost effectiveness ratio for pump therapy compared with daily insulin injections is about $18,000 per life year saved.  
    • Disease Management Program Increases Use of Diabetes Medicines and Reduces Total Health Spending  
    • Treatment of diabetes with medication and other therapy saves $685-$950 in health care costs per patient within 1-2 years.  
    • Every additional dollar spent on statin therapy for diabetes patients without cardiovascular disease has produced health gains valued between $7 and $31.  
    • Every additional dollar spent on screening and treating diabetic eye disease in type 2 diabetics on insulin has produced health gains valued at $36.  
    • Laser treatments save up to $1.6 billion per year through prevention and treatment of blindness in diabetics.  
    • Every additional dollar spent on the overall treatment of type 2 diabetes has produced health gains valued at $1.49.